A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement

被引:3
作者
Yang, Chongtu [1 ,2 ]
Xiong, Bin [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Radiol, Tongji Med Coll, Jiefang Ave 1277, Wuhan 430022, Peoples R China
[2] Hubei Prov Key Lab Mol Imaging, Wuhan, Peoples R China
来源
PORTAL HYPERTENSION & CIRRHOSIS | 2022年 / 1卷 / 02期
基金
中国国家自然科学基金;
关键词
Child-Turcotte-Pugh (CTP) score; Freiburg index of post-TIPS survival (FIPS); model for end-stage liver disease score (MELD); portal hypertension; prognosis; transjugular intrahepatic portosystemic shunt; CHRONIC LIVER-FAILURE; CIRRHOTIC-PATIENTS; MELD SCORE; HEPATIC-ENCEPHALOPATHY; EXTERNAL VALIDATION; REFRACTORY ASCITES; FREIBURG INDEX; CHILD-PUGH; HIGH-RISK; ACUTE DECOMPENSATION;
D O I
10.1002/poh2.28
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patient prognosis after transjugular intrahepatic portosystemic shunt (TIPS) placement is relatively poor and highly heterogeneous; therefore, a prognostic scoring system is essential for survival prediction and risk stratification. Conventional scores include the Child-Turcotte-Pugh (CTP) and model for end-stage liver disease (MELD) scores. The CTP score was created empirically and displayed a high correlation with post-TIPS survival. However, the inclusion of subjective parameters and the use of discrete cut-offs limit its utility. The advantages of the MELD score include its statistical validation and objective and readily available predictors that contribute to its broad application in clinical practice to predict post-TIPS outcomes. In addition, multiple modifications of the MELD score, by incorporating additional predictors (e.g., MELD-Sodium and MELD-Sarcopenia scores), adjusting coefficients (recalibrated MELD score), or combined (MELD 3.0), have been proposed to improve the prognostic ability of the standard MELD score. Despite several updates to conventional scores, a prognostic score has been proposed (based on contemporary data) specifically for outcome prediction after TIPS placement. However, this novel score (the Freiburg index of post-TIPS survival, FIPS) exhibited inconsistent discrimination in external validation studies, and its superiority over conventional scores remains undetermined. Additionally, several tools display potential for application in specific TIPS indications (e.g., bilirubin-platelet grade for refractory ascites), and biomarkers of systemic inflammation, nutritional status, liver disease progression, and cardiac decompensation may provide additional value, but require further validation. Future studies should consider the effect of TIPS placement when exploring predictors, as TIPS is a pathophysiological approach that substantially alters systemic hemodynamics and ameliorates bacterial translocation and malnutrition.
引用
收藏
页码:133 / 144
页数:12
相关论文
共 95 条
  • [1] Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment
    Alessandria, C
    Gaia, S
    Marzano, A
    Venon, WD
    Fadda, M
    Rizzetto, M
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (06) : 607 - 612
  • [2] Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement
    Allegretti, Andrew S.
    Frenk, Nathan E.
    Li, Darrick K.
    Seethapathy, Harish
    Parada, Xavier F. Vela
    Long, Joshua
    Endres, Paul
    Pratt, Daniel S.
    Chung, Raymond T.
    Ganguli, Suvranu
    Irani, Zubin
    Yamada, Kei
    [J]. PLOS ONE, 2019, 14 (05):
  • [3] Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents
    Angermayr, B
    Cejna, M
    Koenig, F
    Karnel, F
    Hackl, F
    Gangl, A
    Peck-Radosavljevic, M
    [J]. HEPATOLOGY, 2003, 38 (04) : 1043 - 1050
  • [4] Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
    Angermayr, B
    Cejna, M
    Karnel, F
    Gschwantler, M
    Koenig, F
    Pidlich, J
    Mendel, H
    Pichler, L
    Wichlas, M
    Kreil, A
    Schmid, M
    Ferlitsch, A
    Lipinski, E
    Brunner, H
    Lammer, J
    Ferenci, P
    Gangl, A
    Peck-Radosavljevic, M
    [J]. GUT, 2003, 52 (06) : 879 - 885
  • [5] Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance
    Artru, Florent
    Miquet, Xavier
    Azahaf, Mustapha
    Labreuche, Julien
    Ntandja Wandji, Line Carolle
    Sergent, Geraldine
    Nobecourt, Amelie
    Toumelin, Pierre
    Lassailly, Guillaume
    Dharancy, Sebastien
    Ernst, Olivier
    Mathurin, Philippe
    Louvet, Alexandre
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (09) : 1516 - 1526
  • [6] Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis
    Azoulay, D
    Castaing, D
    Majno, P
    Saliba, F
    Ichaï, P
    Smail, A
    Delvart, V
    Danaoui, M
    Samuel, D
    Bismuth, H
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (05) : 590 - 597
  • [7] Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites
    Benmassaoud, Amine
    Roccarina, Davide
    Arico, Francesco
    Leandro, Gioacchino
    Yu, Becky
    Cheng, Felix
    Yu, Dominic
    Patch, David
    Tsochatzis, Emmanuel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11) : 1911 - 1914
  • [8] Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt
    Berres, Marie-Luise
    Lehmann, Jennifer
    Jansen, Christian
    Goertzen, Jan
    Meyer, Carsten
    Thomas, Daniel
    Zimmermann, Henning W.
    Kroy, Daniela
    Schumacher, Fabienne
    Strassburg, Christian P.
    Sauerbruch, Tilman
    Trautwein, Christian
    Wasmuth, Hermann E.
    Trebicka, Jonel
    [J]. LIVER INTERNATIONAL, 2016, 36 (03) : 386 - 394
  • [9] CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt
    Berres, Marie-Luise
    Asmacher, Sonja
    Lehmann, Jennifer
    Jansen, Christian
    Goertzen, Jan
    Klein, Sabine
    Meyer, Carsten
    Strunk, Holger M.
    Fimmers, Rolf
    Tacke, Frank
    Strassburg, Christian P.
    Trautwein, Christian
    Sauerbruch, Tilman
    Wasmuth, Hermann Elard
    Trebicka, Jonel
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 332 - 339
  • [10] Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival
    Bettinger, Dominik
    Sturm, Lukas
    Pfaff, Lena
    Hahn, Felix
    Kloeckner, Roman
    Volkwein, Lara
    Praktiknjo, Michael
    Lv, Yong
    Han, Guohong
    Huber, Jan Patrick
    Boettler, Tobias
    Reincke, Marlene
    Klinger, Christoph
    Caca, Karel
    Heinzow, Hauke
    Seifert, Leon Louis
    Weiss, Karl Heinz
    Rupp, Christian
    Piecha, Felix
    Kluwe, Johannes
    Zipprich, Alexander
    Luxenburger, Hendrik
    Neumann-Haefelin, Christoph
    Schmidt, Arthur
    Jansen, Christian
    Meyer, Carsten
    Uschner, Frank E.
    Brol, Maximilian J.
    Trebicka, Jonel
    Rossle, Martin
    Thimme, Robert
    Schultheiss, Michael
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (06) : 1362 - 1372